Global Healthcare Market and Growth Strategy
Think's Opportunity in Clinical Research
New Drug is Developed
1
2
3
4
5
LO
12
BioPharma runs
Phase I trial to determine
safety. Later stage trials
move the product to
approval
⚫ The acquisition will allow
Think to gather further data
• Significant revenue and cost
synergies anticipated
MDBC launches teaching
and training on new drug
through digital clinical
education
• Revenue generated by
helping healthcare
companies market new
products
• Natural revenue synergies
with BioPharma
Think integrates new
research and drug
protocols into clinical
decision support software
ensuring latest
evidence-based care
reaches patient
• Revenue generated via new
SaaS technology solution
Improved data
collection, storage
and analytics create
new SaaS offering to
pharma clients
• Revenue generated via new
SaaS technology solution
Think will leverage its assets
and data within the health
system to generate
real-world evidence,
opening up Phase IV
clinical trials
• Revenue generated via SaaS
technology solutions and
higher revenue late-stage
trials
BioPharma
SERVICES INC.
MD BriefCase
thinkresearch
thinkresearch
Harvesting data to deliver better healthcare outcomes
BioPharma
SERVICES INC.View entire presentation